Skip to main content
Log in

Posterior reversible encephalopathy syndrome in patients with hematologic tumor confers worse outcome

  • Original article
  • Published:
World Journal of Pediatrics Aims and scope Submit manuscript

Abstract

Background

This study aimed to evaluate the clinical features of posterior reversible encephalopathy syndrome (PRES) in children.

Methods

The medical records of 31 patients from five medical centers who were diagnosed with PRES from 2001 to 2013 were retrospectively analyzed. In the 31 patients, 16 were males, and 15 females, with a median age of 7 years (3–12 years). Patients younger than 10 years accounted for 74.2% of the 31 patients.

Results

Seizure, the most common clinical sign, occurred in 29 of the 31 patients. Visual disturbances were also observed in 20 patients. Cerebral imaging abnormalities were bilateral and predominant in the parietal and occipital white matter. In this series, three patients died in the acute phase of PRES. One patient had resolution of neurologic presentation within one week, but no apparent improvement in radiological abnormalities was observed at eight months. One patient showed gradual recovery of both neurologic presentation and radiological abnormalities during follow-up at eight months. One patient developed long-term cortical blindness. All of the PRES patients with hematologic tumor had a worse prognosis than those without hematologic tumor.

Conclusions

Seizure is a prevalent characteristic of children with PRES. Poor prognosis can be seen in PRES patients with hematologic tumor.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Hinchey J, Chaves C, Appignani B, Breen J, Pao L, Wang A, et al. A reversible posterior leukoencephalopathy syndrome. N Engl J Med 1996;334:494–500.

    Article  CAS  PubMed  Google Scholar 

  2. Dillon WP, Rowley H. The reversible posterior cerebral edema syndrome. AJNR Am J Neuroradiol 1998;19: 591.

    CAS  PubMed  Google Scholar 

  3. Trullemans F, Grignard F, Van Camp B, Schots R. Clinical findings and magnetic resonance imaging in severe cyclosporine-related neurotoxicity after allogeneic bone marrow transplantation. Eur J Haematol 2001;67:94–99.

    Article  CAS  PubMed  Google Scholar 

  4. Siebert E, Spors B, Bohner G, Endres M, Liman TG. Posterior reversible encephalopathy syndrome in children: radiological and clinical findings-a retrospective analysis of a German tertiary care center. Eur J Paediatr Neurol 2013;17:169–175.

    Article  CAS  PubMed  Google Scholar 

  5. Lee VH, Wijdicks EF, Manno EM, Rabinstein AA. Clinical spectrum of reversible posterior leukoencephalopathy syndrome. Arch Neurol 2008;65:205–210.

    PubMed  Google Scholar 

  6. Liman TG, Bohner G, Heuschmann PU, Endres M, Siebert E. The clinical and radiological spectrum of posterior reversible encephalopathy syndrome: the retrospective Berlin PRES study. J Neurol 2012;259:155–164.

    Article  CAS  PubMed  Google Scholar 

  7. Young GB. Encephalopathy of infection and systemic inflammation. J Clin Neurophysiol 2013;30:454–461.

    Article  PubMed  Google Scholar 

  8. Kim SJ, Im SA, Lee JW, Chung NG, Cho B, Kim HK, et al. Predisposing factors of posterior reversible encephalopathy syndrome in acute childhood leukemia. Pediatr Neurol 2012;47:436–442.

    Article  PubMed  Google Scholar 

  9. Bartynski WS. Posterior reversible encephalopathy syndrome, part 2: controversies surrounding pathophysiology of vasogenic edema. AJNR Am J Neuroradiol 2008;29:1043–1049.

    Article  CAS  PubMed  Google Scholar 

  10. Panis B, Vlaar AM, van Well GT, Granzen B, Weber JW, Postma AA, et al. Posterior reversible encephalopathy syndrome in paediatric leukaemia. Eur J Paediatr Neurol 2010;14:539–545.

    Article  PubMed  Google Scholar 

  11. Won SC, Kwon SY, Han JW, Choi SY, Lyu CJ. Posterior reversible encephalopathy syndrome in childhood with hematologic/oncologic diseases. J Pediatr Hematol Oncol 2009;31:505–508.

    Article  PubMed  Google Scholar 

  12. Lucchini G, Grioni D, Colombini A, Contri M, De Grandi C, Rovelli A, et al. Encephalopathy syndrome in children with hemato-oncological disorders is not always posterior and reversible. Pediatr Blood Cancer 2008;51:629–633.

    Article  PubMed  Google Scholar 

  13. Ishikura K, Ikeda M, Hamasaki Y, Hataya H, Nishimura G, Hiramoto R, et al. Nephrotic state as a risk factor for developing posterior reversible encephalopathy syndrome in paediatric patients with nephrotic syndrome. Nephrol Dial Transplant 2008;23:2531–2536.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Jing Chen or Li-Ping Zou.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Li, H., Liu, Y., Chen, J. et al. Posterior reversible encephalopathy syndrome in patients with hematologic tumor confers worse outcome. World J Pediatr 11, 245–249 (2015). https://doi.org/10.1007/s12519-015-0027-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12519-015-0027-1

Key words

Navigation